Literature DB >> 27244474

Contribution of Antibody Hydrodynamic Size to Vitreal Clearance Revealed through Rabbit Studies Using a Species-Matched Fab.

Whitney Shatz1, Philip E Hass1, Mary Mathieu1, Hok Seon Kim1, Kim Leach1, Michelle Zhou1, Yongping Crawford1, Amy Shen1, Kathryn Wang1, Debby P Chang1, Mauricio Maia1, Susan R Crowell1, Leslie Dickmann1, Justin M Scheer1, Robert F Kelley1.   

Abstract

We have developed a tool Fab fragment of a rabbit monoclonal antibody that is useful for early evaluation in rabbit models of technologies for long acting delivery (LAD) of proteins to the eye. Using this Fab we show that vitreal clearance can be slowed through increased hydrodynamic size. Fab (G10rabFab) and Fab' (G10rabFab') fragments of a rabbit monoclonal antibody (G10rabIgG) were expressed in Chinese hamster ovary (CHO) cells and purified using antigen-based affinity chromatography. G10rabFab retains antigen-binding upon thermal stress (37 °C) for 8 weeks in phosphate-buffered saline (PBS) and can be detected in rabbit tissues using an antigen-based ELISA. Hydrodynamic radius, measured using quasi-elastic light scattering (QELS), was increased through site-specific modification of the G10rabFab' free cysteine with linear methoxy-polyethylene glycol(PEG)-maleimide of 20000 or 40000 molecular weight. Pharmacokinetic studies upon intravitreal dosing in New Zealand white rabbits were conducted on the G10rabFab and PEGylated G10rabFab'. Results of single and multidose pharmacokinetic experiments yield reproducible results and a vitreal half-life for G10rabFab of 3.2 days. Clearance from the eye is slowed through increased hydrodynamic size, with vitreal half-life showing a linear dependence on hydrodynamic radius (RH). A linear dependence of vitreal half-life on RH suggests that molecule diffusivity makes an important contribution to vitreal clearance. A method for prediction of vitreal half-life from RH measurements is proposed.

Entities:  

Keywords:  PEGylation; hydrodynamic radius; long acting delivery; ocular pharmacokinetics

Mesh:

Substances:

Year:  2016        PMID: 27244474     DOI: 10.1021/acs.molpharmaceut.6b00345

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  10 in total

Review 1.  Next generation antibody drugs: pursuit of the 'high-hanging fruit'.

Authors:  Paul J Carter; Greg A Lazar
Journal:  Nat Rev Drug Discov       Date:  2017-12-01       Impact factor: 84.694

2.  Study on the interaction of Hericium erinaceus mycelium polysaccharides and its degradation products with food additive silica nanoparticles.

Authors:  Erdong Yuan; Shiying Nie; Liangyun Liu; Jiaoyan Ren
Journal:  Food Chem X       Date:  2021-11-26

3.  A Controlled Release System for Long-Acting Intravitreal Delivery of Small Molecules.

Authors:  Nobuo Machinaga; Gary W Ashley; Ralph Reid; Atsushi Yamasaki; Kyosuke Tanaka; Koichi Nakamura; Yoshiyuki Yabe; Yasushi Yoshigae; Daniel V Santi
Journal:  Transl Vis Sci Technol       Date:  2018-08-28       Impact factor: 3.283

Review 4.  Overview of Antibody Drug Delivery.

Authors:  Sahar Awwad; Ukrit Angkawinitwong
Journal:  Pharmaceutics       Date:  2018-07-04       Impact factor: 6.321

5.  Influence of Charge, Hydrophobicity, and Size on Vitreous Pharmacokinetics of Large Molecules.

Authors:  Susan R Crowell; Kathryn Wang; Amin Famili; Whitney Shatz; Kelly M Loyet; Vincent Chang; Yanqiu Liu; Saileta Prabhu; Amrita V Kamath; Robert F Kelley
Journal:  Transl Vis Sci Technol       Date:  2019-11-01       Impact factor: 3.283

Review 6.  Polysaccharides in Ocular Drug Delivery.

Authors:  Natallia Dubashynskaya; Daria Poshina; Sergei Raik; Arto Urtti; Yury A Skorik
Journal:  Pharmaceutics       Date:  2019-12-24       Impact factor: 6.321

Review 7.  Ocular Drug Delivery to the Retina: Current Innovations and Future Perspectives.

Authors:  Hyeong Min Kim; Se Joon Woo
Journal:  Pharmaceutics       Date:  2021-01-15       Impact factor: 6.321

8.  Synthesis and Characterization of Novel Succinyl Chitosan-Dexamethasone Conjugates for Potential Intravitreal Dexamethasone Delivery.

Authors:  Natallia V Dubashynskaya; Anton N Bokatyi; Alexey S Golovkin; Igor V Kudryavtsev; Maria K Serebryakova; Andrey S Trulioff; Yaroslav A Dubrovskii; Yury A Skorik
Journal:  Int J Mol Sci       Date:  2021-10-11       Impact factor: 5.923

9.  Molecular Interaction Characterization Strategies for the Development of New Biotherapeutic Antibody Modalities.

Authors:  Xiangdan Wang; Minh Michael Phan; Ji Li; Herman Gill; Simon Williams; Nidhi Gupta; Valerie Quarmby; Jihong Yang
Journal:  Antibodies (Basel)       Date:  2020-03-25

10.  Extended Pharmacokinetic Model of the Intravitreal Injections of Macromolecules in Rabbits. Part 2: Parameter Estimation Based on Concentration Dynamics in the Vitreous, Retina, and Aqueous Humor.

Authors:  Marko Lamminsalo; Timo Karvinen; Astrid Subrizi; Arto Urtti; Veli-Pekka Ranta
Journal:  Pharm Res       Date:  2020-10-22       Impact factor: 4.200

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.